A combination therapy with secukinumab and dupilumab in Netherton syndrome: A prospective pilot study

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Academy of Dermatology 2024-12, Vol.91 (6), p.1258-1260
Hauptverfasser: Liu, Taoming, Tang, Manman, Liu, Jiao, Kong, Tinghui, Tian, Yuyang, Yang, Sai, Zhang, Jiao, Ji, Suyun, Lin, Zhimiao, Xue, Ruzeng, Ding, Yan, Yang, Bin, Liang, Yunsheng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1260
container_issue 6
container_start_page 1258
container_title Journal of the American Academy of Dermatology
container_volume 91
creator Liu, Taoming
Tang, Manman
Liu, Jiao
Kong, Tinghui
Tian, Yuyang
Yang, Sai
Zhang, Jiao
Ji, Suyun
Lin, Zhimiao
Xue, Ruzeng
Ding, Yan
Yang, Bin
Liang, Yunsheng
description
doi_str_mv 10.1016/j.jaad.2024.07.1513
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3097149096</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0190962224027257</els_id><sourcerecordid>3097149096</sourcerecordid><originalsourceid>FETCH-LOGICAL-c239t-eb9d436e672963a5dc4429e6e2657556f82afd933fc22037a496951153ae8bd93</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMouq7-AkFy9NKajzbZCB4W8QtEL3oOaTLFrNsPm1TZf2_qqkdPQ5jnnZk8CJ1QklNCxfkqXxnjckZYkROZ05LyHTSjRMlMyIXcRTNCFcmUYOwAHYawIoSogst9dMAVXTAhxQzBEtuuqXxrou9aHF9hMP0Gf_r4igPY8c23Y2MqbFqH3dj79ffLt_gRJjamTNi0bugauMBL3A9d6MFG_wE4wV3EIY5uc4T2arMOcPxT5-jl5vr56i57eLq9v1o-ZJZxFTOolCu4ACGZEtyUzhYFUyCAiVKWpagXzNROcV5bxgiXplBClZSW3MCiSo05OtvOTXe8jxCibnywsF6bFroxaJ7k0EKRNH2O-Ba16eQwQK37wTdm2GhK9ORXr_TkV09-NZF68ptSpz8LxqoB95f5FZqAyy0A6ZsfHgYdrIfWgvND8qJd5_9d8AUviIzu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3097149096</pqid></control><display><type>article</type><title>A combination therapy with secukinumab and dupilumab in Netherton syndrome: A prospective pilot study</title><source>Access via ScienceDirect (Elsevier)</source><creator>Liu, Taoming ; Tang, Manman ; Liu, Jiao ; Kong, Tinghui ; Tian, Yuyang ; Yang, Sai ; Zhang, Jiao ; Ji, Suyun ; Lin, Zhimiao ; Xue, Ruzeng ; Ding, Yan ; Yang, Bin ; Liang, Yunsheng</creator><creatorcontrib>Liu, Taoming ; Tang, Manman ; Liu, Jiao ; Kong, Tinghui ; Tian, Yuyang ; Yang, Sai ; Zhang, Jiao ; Ji, Suyun ; Lin, Zhimiao ; Xue, Ruzeng ; Ding, Yan ; Yang, Bin ; Liang, Yunsheng</creatorcontrib><identifier>ISSN: 0190-9622</identifier><identifier>ISSN: 1097-6787</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2024.07.1513</identifier><identifier>PMID: 39182676</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>combination therapy ; dupilumab ; Netherton syndrome ; secukinumab</subject><ispartof>Journal of the American Academy of Dermatology, 2024-12, Vol.91 (6), p.1258-1260</ispartof><rights>2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c239t-eb9d436e672963a5dc4429e6e2657556f82afd933fc22037a496951153ae8bd93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaad.2024.07.1513$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39182676$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Taoming</creatorcontrib><creatorcontrib>Tang, Manman</creatorcontrib><creatorcontrib>Liu, Jiao</creatorcontrib><creatorcontrib>Kong, Tinghui</creatorcontrib><creatorcontrib>Tian, Yuyang</creatorcontrib><creatorcontrib>Yang, Sai</creatorcontrib><creatorcontrib>Zhang, Jiao</creatorcontrib><creatorcontrib>Ji, Suyun</creatorcontrib><creatorcontrib>Lin, Zhimiao</creatorcontrib><creatorcontrib>Xue, Ruzeng</creatorcontrib><creatorcontrib>Ding, Yan</creatorcontrib><creatorcontrib>Yang, Bin</creatorcontrib><creatorcontrib>Liang, Yunsheng</creatorcontrib><title>A combination therapy with secukinumab and dupilumab in Netherton syndrome: A prospective pilot study</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><subject>combination therapy</subject><subject>dupilumab</subject><subject>Netherton syndrome</subject><subject>secukinumab</subject><issn>0190-9622</issn><issn>1097-6787</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAQhoMouq7-AkFy9NKajzbZCB4W8QtEL3oOaTLFrNsPm1TZf2_qqkdPQ5jnnZk8CJ1QklNCxfkqXxnjckZYkROZ05LyHTSjRMlMyIXcRTNCFcmUYOwAHYawIoSogst9dMAVXTAhxQzBEtuuqXxrou9aHF9hMP0Gf_r4igPY8c23Y2MqbFqH3dj79ffLt_gRJjamTNi0bugauMBL3A9d6MFG_wE4wV3EIY5uc4T2arMOcPxT5-jl5vr56i57eLq9v1o-ZJZxFTOolCu4ACGZEtyUzhYFUyCAiVKWpagXzNROcV5bxgiXplBClZSW3MCiSo05OtvOTXe8jxCibnywsF6bFroxaJ7k0EKRNH2O-Ba16eQwQK37wTdm2GhK9ORXr_TkV09-NZF68ptSpz8LxqoB95f5FZqAyy0A6ZsfHgYdrIfWgvND8qJd5_9d8AUviIzu</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Liu, Taoming</creator><creator>Tang, Manman</creator><creator>Liu, Jiao</creator><creator>Kong, Tinghui</creator><creator>Tian, Yuyang</creator><creator>Yang, Sai</creator><creator>Zhang, Jiao</creator><creator>Ji, Suyun</creator><creator>Lin, Zhimiao</creator><creator>Xue, Ruzeng</creator><creator>Ding, Yan</creator><creator>Yang, Bin</creator><creator>Liang, Yunsheng</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202412</creationdate><title>A combination therapy with secukinumab and dupilumab in Netherton syndrome: A prospective pilot study</title><author>Liu, Taoming ; Tang, Manman ; Liu, Jiao ; Kong, Tinghui ; Tian, Yuyang ; Yang, Sai ; Zhang, Jiao ; Ji, Suyun ; Lin, Zhimiao ; Xue, Ruzeng ; Ding, Yan ; Yang, Bin ; Liang, Yunsheng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c239t-eb9d436e672963a5dc4429e6e2657556f82afd933fc22037a496951153ae8bd93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>combination therapy</topic><topic>dupilumab</topic><topic>Netherton syndrome</topic><topic>secukinumab</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Taoming</creatorcontrib><creatorcontrib>Tang, Manman</creatorcontrib><creatorcontrib>Liu, Jiao</creatorcontrib><creatorcontrib>Kong, Tinghui</creatorcontrib><creatorcontrib>Tian, Yuyang</creatorcontrib><creatorcontrib>Yang, Sai</creatorcontrib><creatorcontrib>Zhang, Jiao</creatorcontrib><creatorcontrib>Ji, Suyun</creatorcontrib><creatorcontrib>Lin, Zhimiao</creatorcontrib><creatorcontrib>Xue, Ruzeng</creatorcontrib><creatorcontrib>Ding, Yan</creatorcontrib><creatorcontrib>Yang, Bin</creatorcontrib><creatorcontrib>Liang, Yunsheng</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Taoming</au><au>Tang, Manman</au><au>Liu, Jiao</au><au>Kong, Tinghui</au><au>Tian, Yuyang</au><au>Yang, Sai</au><au>Zhang, Jiao</au><au>Ji, Suyun</au><au>Lin, Zhimiao</au><au>Xue, Ruzeng</au><au>Ding, Yan</au><au>Yang, Bin</au><au>Liang, Yunsheng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A combination therapy with secukinumab and dupilumab in Netherton syndrome: A prospective pilot study</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2024-12</date><risdate>2024</risdate><volume>91</volume><issue>6</issue><spage>1258</spage><epage>1260</epage><pages>1258-1260</pages><issn>0190-9622</issn><issn>1097-6787</issn><eissn>1097-6787</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39182676</pmid><doi>10.1016/j.jaad.2024.07.1513</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0190-9622
ispartof Journal of the American Academy of Dermatology, 2024-12, Vol.91 (6), p.1258-1260
issn 0190-9622
1097-6787
1097-6787
language eng
recordid cdi_proquest_miscellaneous_3097149096
source Access via ScienceDirect (Elsevier)
subjects combination therapy
dupilumab
Netherton syndrome
secukinumab
title A combination therapy with secukinumab and dupilumab in Netherton syndrome: A prospective pilot study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A44%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20combination%20therapy%20with%20secukinumab%20and%20dupilumab%20in%20Netherton%20syndrome:%20A%20prospective%20pilot%20study&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Liu,%20Taoming&rft.date=2024-12&rft.volume=91&rft.issue=6&rft.spage=1258&rft.epage=1260&rft.pages=1258-1260&rft.issn=0190-9622&rft.eissn=1097-6787&rft_id=info:doi/10.1016/j.jaad.2024.07.1513&rft_dat=%3Cproquest_cross%3E3097149096%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3097149096&rft_id=info:pmid/39182676&rft_els_id=S0190962224027257&rfr_iscdi=true